SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001017491-14-000091
Filing Date
2014-10-08
Accepted
2014-10-07 20:10:50
Documents
20
Period of Report
2014-10-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kforcorppres10x8x14.htm 8-K 29667
2 CORPORATE PRESENTATION apricorppres10814.htm EX-99.1 20724
3 apricorppres10814001.jpg GRAPHIC 59960
4 apricorppres10814002.jpg GRAPHIC 369772
5 apricorppres10814003.jpg GRAPHIC 207292
6 apricorppres10814004.jpg GRAPHIC 163751
7 apricorppres10814005.jpg GRAPHIC 51663
8 apricorppres10814006.jpg GRAPHIC 258293
9 apricorppres10814007.jpg GRAPHIC 133962
10 apricorppres10814008.jpg GRAPHIC 162130
11 apricorppres10814009.jpg GRAPHIC 239422
12 apricorppres10814010.jpg GRAPHIC 58060
13 apricorppres10814011.jpg GRAPHIC 215170
14 apricorppres10814012.jpg GRAPHIC 203029
15 apricorppres10814013.jpg GRAPHIC 122804
16 apricorppres10814014.jpg GRAPHIC 196893
17 apricorppres10814015.jpg GRAPHIC 108678
18 apricorppres10814016.jpg GRAPHIC 193887
19 apricorppres10814017.jpg GRAPHIC 59960
20 apricorppres10814018.jpg GRAPHIC 116616
  Complete submission text file 0001017491-14-000091.txt   4079138
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22245 | Film No.: 141146564
SIC: 2834 Pharmaceutical Preparations